Terbinafine Tablet (Terbinafine Hydrochloride)

Adult dose

As terbinafine, administer 125 mg once, twice daily or 250 mg once daily. The duration of treatment varies by condition: 1) Dermatophytosis - Tinea pedis (interdigital type, plantar type/moccasin type): 2 to 6 weeks - Tinea corporis: 2 to 4 weeks - Tinea cruris (jock itch): 2 to 4 weeks 2) Onychomycosis - Generally administered for 6 weeks to 3 months. If the infection is on the fingernails or relatively small toes, or in younger patients, the treatment duration may be reduced to less than 3 months. The treatment period for toenail infections is usually sufficient at 3 months, but some patients may take 6 months or more. If the patient's nail growth rate is slow, the treatment duration may be prolonged.

Child dose

Administered to children aged 2 years and older. - Tinea capitis: 4 weeks - 1) Body weight less than 20 kg (under 5 years): administer 62.5 mg once daily. - 2) Body weight 20 to 40 kg (5 years to

This medication is not recommended for patients with chronic liver disease or active liver disease. The patient's liver health should be assessed before prescribing, and regular liver function tests should be performed. If liver function worsens or liver-related symptoms appear, discontinue use immediately and consult a physician. Patients with blood disorders or severely impaired kidney function, children under 2 years of age, and nursing women should not use this medication. Elderly patients or children with low body weight, and patients with mildly impaired kidney function should use this medication with caution, and if severe skin reactions occur, they should discontinue use immediately. This medication can cause adverse reactions in various systems including the liver, blood, skin, muscles, digestive system, and nervous system, so any unusual symptoms should be reported to healthcare professionals immediately. Caution is needed while driving or operating machinery, as dizziness may occur. If taken with other medications, interactions may occur, so patients should inform their physician or pharmacist about any other medications being taken, as dosage adjustments may be necessary. Women who are pregnant or may become pregnant should use this medication with caution, and nursing mothers should discontinue breastfeeding while using this medication. In the case of overdose, symptoms such as headache, nausea, abdominal pain, and dizziness may occur; if these symptoms present, seek medical attention immediately. This medication should be kept out of reach of children and stored in a cool, dry place, avoiding direct sunlight.

Serious side effects

Hives, facial swelling, angioedema, severe swelling (edema), tightness in the chest, shortness of breath, chest pressure, anaphylactic reaction, severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis, mucosal membrane syndrome), severe rash with high fever, blisters, peeling skin, pain in oral/ocular mucosa, liver failure, hepatitis, cholestasis, jaundice, rhabdomyolysis due to kidney function deterioration, thrombocytopenia, pancytopenia, and anosmia.

Mild side effects

Rash, itching, fever, nausea, vomiting, loss of appetite, fatigue, musculoskeletal reactions (joint pain, muscle pain), weakness, headache, taste disturbance, dizziness, drowsiness, sensory disturbances, sensory loss, decreased attention, insomnia, elevated BUN, frequent urination, visual disturbances, tinnitus, increased total cholesterol, increased triglycerides, tongue discoloration, palpitations, menstrual irregularities, fatigue, weight loss

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and it is advisable to keep it at room temperature, away from extreme heat or cold.

Appearance

White to pale yellow round tablets

Package unit

30 tablets/bottle, 100 tablets/bottle